Amarin reported $142.04M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
Aerie Pharmaceuticals AERI:US $ 29.31M 2.13M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amarin AMRN:US $ 142.04M 12.45M
Arena Pharmaceuticals ARNA:US $ 0M 0M
AstraZeneca AZN:LN 9866M 1646M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Epizyme EPZM:US $ 5.2M 7.81M
Esperion Therapeutics ESPR:US $ 14.41M 26.25M
GlaxoSmithKline GSK:LN 9077M 985M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Novartis NOVN:VX SF 13367M 73M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M